Anti-IFT140 monoclonal antibody

Pre-made anti-IFT140 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to IFT140/IFT140 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2889-Ab-1/ GM-Tg-hg-IP2889-Ab-2Anti-Human IFT140 monoclonal antibodyHuman
GM-Tg-rg-IP2889-Ab-1/ GM-Tg-rg-IP2889-Ab-2Anti-Rat IFT140 monoclonal antibodyRat
GM-Tg-mg-IP2889-Ab-1/ GM-Tg-mg-IP2889-Ab-2Anti-Mouse IFT140 monoclonal antibodyMouse
GM-Tg-cynog-IP2889-Ab-1/ GM-Tg-cynog-IP2889-Ab-2Anti-Cynomolgus/ Rhesus macaque IFT140 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2889-Ab-1/ GM-Tg-felg-IP2889-Ab-2Anti-Feline IFT140 monoclonal antibodyFeline
GM-Tg-cang-IP2889-Ab-1/ GM-Tg-cang-IP2889-Ab-2Anti-Canine IFT140 monoclonal antibodyCanine
GM-Tg-bovg-IP2889-Ab-1/ GM-Tg-bovg-IP2889-Ab-2Anti-Bovine IFT140 monoclonal antibodyBovine
GM-Tg-equg-IP2889-Ab-1/ GM-Tg-equg-IP2889-Ab-2Anti-Equine IFT140 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2889-Ab-1/ GM-Tg-hg-IP2889-Ab-2; GM-Tg-rg-IP2889-Ab-1/ GM-Tg-rg-IP2889-Ab-2;
GM-Tg-mg-IP2889-Ab-1/ GM-Tg-mg-IP2889-Ab-2; GM-Tg-cynog-IP2889-Ab-1/ GM-Tg-cynog-IP2889-Ab-2;
GM-Tg-felg-IP2889-Ab-1/ GM-Tg-felg-IP2889-Ab-2; GM-Tg-cang-IP2889-Ab-1/ GM-Tg-cang-IP2889-Ab-2;
GM-Tg-bovg-IP2889-Ab-1/ GM-Tg-bovg-IP2889-Ab-2; GM-Tg-equg-IP2889-Ab-1/ GM-Tg-equg-IP2889-Ab-2
Products NameAnti-IFT140 monoclonal antibody
Formatmab
Target NameIFT140
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-IFT140 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2889-Ag-1Recombinant multi-species IF140/ IFT140/ MZSDS protein


    Target information

    Target IDGM-IP2889
    Target NameIFT140
    Gene ID9742,106633,100362124,701568,490075,101084760,100139697,100065433
    Gene Symbol and Synonymsc305C8.4,c380F5.1,gs114,IFT140,mKIAA0590,MZSDS,RP80,SRTD9,Tce5,WDTC2
    Uniprot AccessionQ96RY7
    Uniprot Entry NameIF140_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000187535
    Target ClassificationN/A

    The target: IFT140, gene name: IFT140, also named as MZSDS, RP80, SRTD9, WDTC2, c305C8.4, c380F5.1, gs114. This gene encodes one of the subunits of the intraflagellar transport (IFT) complex A. Intraflagellar transport is involved in the genesis, resorption and signaling of primary cilia. The primary cilium is a microtubule-based sensory organelle at the surface of most quiescent mammalian cells, that receives signals from its environment, such as the flow of fluid, light or odors, and transduces those signals to the nucleus. Loss of the corresponding protein in mouse results in renal cystic disease. [provided by RefSeq, Jun 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.